Israel’s Hebrew University recently announced that the oldest cannabis study society, The International Cannabinoid Research Society (ICRS), will hold its prestigious global conference there in 2021.
ICRS have been holding cornerstone, global conferences for decades, exploring medical cannabis and its effects on things like autoimmune disorders, epilepsy, pain, PTSD, metabolism, obesity, cancer and other illnesses.
Come 2021, and hundreds of doctors, researchers, growers and patients alike will convene at the Hebrew University campus in Israel’s capital, Jerusalem, hosted also by Hebrew University’s Multidisciplinary Center on Cannabinoid Research.
ICRS Executive Director Prof. Cecilia Hillard told the Jerusalem Post publication in Israel, “Prof. Raphael Mechoulam was the first to publish the structure of the active principal of cannabis, THC, and was also the first to identify an endogenous cannabinoid, anandamide.”
Hillard added that, “Just as impressive is the current state of cannabinoid research in Jerusalem and Israel at large, including the Multidisciplinary Center on Cannabinoid Research led by Dr. Joseph Tam. We are looking forward to visiting Jerusalem and to an exciting and informative conference.”
Israel has been one of the countries in the developed world at the forefront when it comes to medical cannabis research, innovation, cultivation and development. In this respect, the Jewish State has benefited from not being subject to strict federal laws like in the states, restricting even medical research on cannabis.
It’s also interesting that Israel seems to be following in the footsteps of numerous states in America who have already made legal provisions for possession of small amounts of cannabis, even for recreational use. A bill which is soon to pass in the Israeli parliament aims to do the same.
[Image credit- Wikipedia]